Who invested in Neuraltus Pharmaceuticals

4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$39Mraised across 4 rounds since 2009, from 4 sources

$17MSeries A$9.6MSeries B$1.5MVenture$11MSeries A

Latest round: Series A, $11MMay 2012
Biggest round: $17MSeries A · Mar 2009
Step-upi: 7.4×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201020112012

$17MSeries A$9.6MSeries B$1.5MVenture$11MSeries A

First round: Series A, $17M
Biggest round: $17M
Usual gap between rounds: 2 months

The rounds

May 2012
Series A$11M
No investor was named in the report.
Reported by sec.govSEC filing: $11M sold, first sale Dec 2011
Apr 2012
Venture$1.5M2 returning
- Adams Street Partners
- Latterell Venture Partners
From a historical funding recordSEC filing: $11M sold, first sale Dec 2011
Jan 2012
Series B$9.6M3 returning
Reported by onbiovc.comSEC filing: $9.6M sold, first sale Dec 2011
Mar 2009
Series A$17M3 new
Reported by neuraltus.comSEC filing: $4.9M sold, first sale Mar 2009

Founders and team

From the SEC filings it signed: 2 on the team.

John WhelanExecutive Officeri
Richard CaseyExecutive Officer, Directori

On the board, as filediAnnette BianchiDonald McGovernJames Woody

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2009Series B2012Venture2012Series A2012

Adams Street Partners

Latterell Venture Partners

VantagePoint Capital Partners

Everyone who backed them

Adams Street PartnersVC firm3rounds

Latterell Venture PartnersVC firm3rounds

VantagePoint Capital PartnersVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Neuraltus Pharmaceuticals

Who invested in Neuraltus Pharmaceuticals?

Neuraltus Pharmaceuticals's investors include Adams Street Partners, Latterell Venture Partners and VantagePoint Capital Partners.

How much has Neuraltus Pharmaceuticals raised?

Neuraltus Pharmaceuticals has raised $39M across 4 rounds since 2009.

When did Neuraltus Pharmaceuticals last raise?

Neuraltus Pharmaceuticals's most recent round was a Series A of $11M in May 2012.

What was Neuraltus Pharmaceuticals's biggest round?

Neuraltus Pharmaceuticals's largest round on record is $17M (Series A), in Mar 2009.

Who backed Neuraltus Pharmaceuticals first?

Neuraltus Pharmaceuticals's first round on record, in Mar 2009, was backed by Adams Street Partners, VantagePoint Capital Partners and Latterell Venture Partners.